Literature DB >> 18338318

Dynamic regression hazards models for relative survival.

Giuliana Cortese1, Thomas H Scheike.   

Abstract

A natural way of modelling relative survival through regression analysis is to assume an additive form between the expected population hazard and the excess hazard due to the presence of an additional cause of mortality. Within this context, the existing approaches in the parametric, semiparametric and non-parametric setting are compared and discussed. We study the additive excess hazards models, where the excess hazard is on additive form. This makes it possible to assess the importance of time-varying effects for regression models in the relative survival framework. We show how recent developments can be used to make inferential statements about the non-parametric version of the model. This makes it possible to test the key hypothesis that an excess risk effect is time varying in contrast to being constant over time. In case some covariate effects are constant, we show how the semiparametric additive risk model can be considered in the excess risk setting, providing a better and more useful summary of the data. Estimators have explicit form and inference based on a resampling scheme is presented for both the non-parametric and semiparametric models. We also describe a new suggestion for goodness of fit of relative survival models, which consists on statistical and graphical tests based on cumulative martingale residuals. This is illustrated on the semiparametric model with proportional excess hazards. We analyze data from the TRACE study using different approaches and show the need for more flexible models in relative survival. 2008 John Wiley & Sons, Ltd

Entities:  

Mesh:

Year:  2008        PMID: 18338318      PMCID: PMC2737139          DOI: 10.1002/sim.3242

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  18 in total

1.  Goodness of fit of relative survival models.

Authors:  Janez Stare; Maja Pohar; Robin Henderson
Journal:  Stat Med       Date:  2005-12-30       Impact factor: 2.373

2.  Additive and multiplicative covariate regression models for relative survival incorporating fractional polynomials for time-dependent effects.

Authors:  Paul C Lambert; Lucy K Smith; David R Jones; Johannes L Botha
Journal:  Stat Med       Date:  2005-12-30       Impact factor: 2.373

3.  A method for checking regression models in survival analysis based on the risk score.

Authors:  J K Grønnesby; O Borgan
Journal:  Lifetime Data Anal       Date:  1996       Impact factor: 1.588

4.  Long-term survival of breast cancer in Norway by age and clinical stage.

Authors:  P H Zahl; S Tretli
Journal:  Stat Med       Date:  1997-07-15       Impact factor: 2.373

5.  Does in-hospital ventricular fibrillation affect prognosis after myocardial infarction?

Authors:  G V Jensen; C Torp-Pedersen; P Hildebrandt; L Kober; F E Nielsen; T Melchior; T Joen; P K Andersen
Journal:  Eur Heart J       Date:  1997-06       Impact factor: 29.983

6.  A linear regression model for the analysis of life times.

Authors:  O O Aalen
Journal:  Stat Med       Date:  1989-08       Impact factor: 2.373

7.  Simple parametric and nonparametric models for excess and relative mortality.

Authors:  P K Andersen; M Vaeth
Journal:  Biometrics       Date:  1989-06       Impact factor: 2.571

8.  Further results on the non-parametric linear regression model in survival analysis.

Authors:  O O Aalen
Journal:  Stat Med       Date:  1993-09-15       Impact factor: 2.373

9.  A clinical trial of the angiotensin-converting-enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction. Trandolapril Cardiac Evaluation (TRACE) Study Group.

Authors:  L Køber; C Torp-Pedersen; J E Carlsen; H Bagger; P Eliasen; K Lyngborg; J Videbaek; D S Cole; L Auclert; N C Pauly
Journal:  N Engl J Med       Date:  1995-12-21       Impact factor: 91.245

10.  A proportional regression model for 20 year survival of colon cancer in Norway.

Authors:  P H Zahl
Journal:  Stat Med       Date:  1995-06-15       Impact factor: 2.373

View more
  7 in total

1.  Performance of two formal tests based on martingales residuals to check the proportional hazard assumption and the functional form of the prognostic factors in flexible parametric excess hazard models.

Authors:  Coraline Danieli; Nadine Bossard; Laurent Roche; Aurelien Belot; Zoe Uhry; Hadrien Charvat; Laurent Remontet
Journal:  Biostatistics       Date:  2017-07-01       Impact factor: 5.899

2.  Partitioning of excess mortality in population-based cancer patient survival studies using flexible parametric survival models.

Authors:  Sandra Eloranta; Paul C Lambert; Therese M L Andersson; Kamila Czene; Per Hall; Magnus Björkholm; Paul W Dickman
Journal:  BMC Med Res Methodol       Date:  2012-06-24       Impact factor: 4.615

3.  Appraising relative and excess mortality in population-based studies of chronic diseases such as end-stage renal disease.

Authors:  Caroline Elie; Y De Rycke; Jp Jais; P Landais
Journal:  Clin Epidemiol       Date:  2011-05-10       Impact factor: 4.790

4.  Understanding disparities in cancer prognosis: An extension of mediation analysis to the relative survival framework.

Authors:  Elisavet Syriopoulou; Mark J Rutherford; Paul C Lambert
Journal:  Biom J       Date:  2020-12-14       Impact factor: 2.207

5.  Marginal measures and causal effects using the relative survival framework.

Authors:  Elisavet Syriopoulou; Mark J Rutherford; Paul C Lambert
Journal:  Int J Epidemiol       Date:  2020-04-01       Impact factor: 7.196

6.  Prediction of cancer survival for cohorts of patients most recently diagnosed using multi-model inference.

Authors:  Camille Maringe; Aurélien Belot; Bernard Rachet
Journal:  Stat Methods Med Res       Date:  2020-12       Impact factor: 3.021

7.  Sinonasal B-cell lymphomas: A nationwide cohort study, with an emphasis on the prognosis and the recurrence pattern of primary diffuse large B-cell lymphoma.

Authors:  Patrick R G Eriksen; Erik Clasen-Linde; Peter de Nully Brown; Laura Haunstrup; Mette Christoffersen; Peter Asdahl; Troels Møller Thomsen; Cecilie Dupont Harwood; Steffen Heegaard; Christian von Buchwald
Journal:  Hematol Oncol       Date:  2022-02-06       Impact factor: 4.850

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.